Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Commercial Services » Miscellaneous Commercial Services
|CRL||Charles River Laboratories International, Inc.||-3.36%||417.93||4.5%||$174.10m|
|MRVI||Maravai Lifesciences Holdings, Inc.||-3.57%||47.27||0.0%||$124.12m|
|RELY||Remitly Global, Inc.||-7.07%||38.10||0.8%||$119.73m|
|FLT||FLEETCOR Technologies, Inc.||-1.28%||266.85||3.6%||$111.93m|
|TAL||TAL Education Group||-3.03%||4.48||0.7%||$88.80m|
|FOUR||Shift4 Payments, Inc.||-3.83%||82.21||0.0%||$87.46m|
|BR||Broadridge Financial Solutions, Inc.||-0.50%||167.40||1.5%||$74.40m|
Adagio Therapeutics, Inc. engages in the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The firm develops antibodies that can neutralize SARS-CoV-2, SARS-CoV-1, and additional emergent coronaviruses. It offers, ADG20, a monoclonal antibody targeting the spike protein of SARS-CoV-2 and related coronaviruses. The company was founded by Tillman U. Gerngross, Ren? Russo and Laura Walker on June 3, 2020 and is headquartered in Waltham, MA.